Exact Sciences announces third quarter 2021 results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Exact Sciences (EXAS) Misses Q3 EPS by 12c, Revenue Beats, Offers FY Guidance
November 2, 2021 4:26 PM EDTExact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.97), $0.12 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $456.4 million versus the consensus estimate of $430.55 million.
GUIDANCE:
Exact Sciences sees 2021 revenue of $1.72-1.74 billion, versus the consensus of $1.73... More
